Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those companies that sell their drugs at higher prices than the average of the prices in other wealthy nations.
https://www.propublica.org/article/why-americans-pay-more-for-prescription-drugs?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
#News #Drugs #Pharma #Health #Healthcare #Cancer #Business #Congress
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs
—
A ProPublica investigation found that for more than a decade, the FDA gave substandard factories banned from the United States a special pass to keep sending drugs to an unsuspecting public.
https://www.propublica.org/article/fda-drug-loophole-sun-pharma?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
The FDA allowed into the United States at least 150 drugs or their ingredients made at banned factories that were found to have mold, foul water, dirty labs or fraudulent testing protocols.
Key takeaways of our investigation:
https://www.propublica.org/article/fda-drug-safety-foreign-manufacturers-takeaways?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
#News #FDA #Drugs #Safety #Health #Medicine #Pharma #Science #Lab
